MedPath

Efficacy of a new Vitamin E foam in prevention of early skin damage in patients undergoing radiotherapy

Completed
Conditions
Skin damage after radiotherapy
Cancer
Breast
Registration Number
ISRCTN28188789
Lead Sponsor
Mipharm (Italy)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
80
Inclusion Criteria

Patients undergoing radiotherapy for breast or thoracic cancer

Exclusion Criteria

Known sensibility to topical Vitamin E

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Radiation Therapy Oncology Group (RTOG) skin score<br>2. Skin damage score
Secondary Outcome Measures
NameTimeMethod
Tolerability
© Copyright 2025. All Rights Reserved by MedPath